Effects of temporal IFNγ exposure on macrophage phenotype and secretory profile: exploring GMP-Compliant production of a novel subtype of regulatory macrophages (Mreg IFNγ0 ) for potential cell therapeutic applications.
Karina ZittaLars HummitzschFrank LichteFred FändrichMarkus SteinfathChristine EimerSebastian KapahnkeMatthias BuergerKatharina HessMelanie RuschRene RuschRouven BerndMartin AlbrechtPublished in: Journal of translational medicine (2024)
may therefore have the potential to serve as cellular therapeutics for clinical applications beyond those covered by M2-like Mreg, including immunomodulation and tumor treatment.